FDA Adverse Event Malfunction Summary report: N

DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM

MDR report key: 6090652 · Received November 9, 2016

Report

Report Number
3004753838-2016-93372
Event Type
Malfunction
Date Received
November 9, 2016
Date of Event
October 18, 2016
Report Date
October 18, 2016
Manufacturer
DEXCOM, INC.
Product Code
MDS
UDI-DI
00386270000224
PMA / PMN Number
P120005
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

DEXCOM WAS MADE AWARE ON (B)(6) 2016, THAT ON (B)(6) 2016, THERE WAS AN INACCURACY BETWEEN THE CONTINUOUS GLUCOSE MONITOR (CGM) AND THE BLOOD GLUCOSE (BG) METER. THE SENSOR WAS INSERTED AT THE BACK ON (B)(6) 2016. NO ADDITIONAL EVENT OR PATIENT INFORMATION IS AVAILABLE. DATA WAS PROVIDED. REVIEW OF THE DATA LOG CONFIRMED THE REPORTED INACCURACY. A ROOT CAUSE COULD NOT BE DETERMINED VIA DATA. LABELING INDICATES: DO NOT INSERT THE SENSOR COMPONENT OF THE DEXCOM G5 MOBILE SYSTEM IN A SITE OTHER THAN THE BELLY/ABDOMEN (AGES 2 YEARS AND OLDER) OR THE UPPER BUTTOCKS (AGES 2 TO 17 YEARS). THE PLACEMENT AND INSERTION OF THE SENSOR COMPONENT OF THE DEXCOM G5 MOBILE SYSTEM IS NOT APPROVED FOR OTHER SITES. IF PLACED IN OTHER AREAS, THE DEXCOM G5 MOBILE SYSTEM MAY NOT FUNCTION PROPERLY.

Description of Event or Problem · 1

THE TRANSMITTER WAS RETURNED FOR EVALUATION. A VISUAL INSPECTION WAS PERFORMED AND NO DEFECTS WERE FOUND. FUNCTIONAL TESTING AND A PAIRING TEST WAS PERFORMEC AND THE TESTS PASSED. THE REPORTED EVENT OF INACCURACIES WAS NOT CONFIRMED BECAUSE INFORMATION ABOUT INACCURACIES CANNOT BE OBTAINED FROM THE TRANSMITTER. A ROOT CAUSE COULD NOT BE DETERMINED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
739966 DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM CONTINUOUS GLUCOSE MONITOR MDS DEXCOM, INC. 9438-06 5214642 00386270000224

Patients

Seq Age Sex Outcome Treatment
1 11 YR